The Pennant Group, Inc. (PNTG)
USD 28.15
(-3.63%)
USD 28.15
(-3.63%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 25.16 Million USD | 27.94% |
| 2022 | 19.67 Million USD | 319.02% |
| 2021 | 4.69 Million USD | -75.18% |
| 2020 | 18.91 Million USD | 233.63% |
| 2019 | 5.67 Million USD | -72.52% |
| 2018 | 20.63 Million USD | 33.95% |
| 2017 | 15.4 Million USD | 18.64% |
| 2016 | 12.98 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 9.96 Million USD | 36.85% |
| 2024 Q1 | 7.27 Million USD | -0.83% |
| 2023 Q1 | 4.28 Million USD | -32.96% |
| 2023 FY | 25.16 Million USD | 27.94% |
| 2023 Q2 | 6.26 Million USD | 46.29% |
| 2023 Q3 | 7.06 Million USD | 12.78% |
| 2023 Q4 | 7.33 Million USD | 3.94% |
| 2022 Q4 | 6.38 Million USD | -10.64% |
| 2022 FY | 19.67 Million USD | 319.02% |
| 2022 Q3 | 7.14 Million USD | 106.06% |
| 2022 Q2 | 3.46 Million USD | 49.05% |
| 2022 Q1 | 2.32 Million USD | 206.26% |
| 2021 Q2 | 3.56 Million USD | 121.26% |
| 2021 Q1 | 1.61 Million USD | -60.58% |
| 2021 FY | 4.69 Million USD | -75.18% |
| 2021 Q3 | 1.7 Million USD | -52.31% |
| 2021 Q4 | -2.18 Million USD | -228.61% |
| 2020 Q2 | 6.07 Million USD | 42.21% |
| 2020 FY | 18.91 Million USD | 233.63% |
| 2020 Q4 | 4.09 Million USD | -8.62% |
| 2020 Q3 | 4.47 Million USD | -26.29% |
| 2020 Q1 | 4.27 Million USD | 406.24% |
| 2019 Q2 | 3.31 Million USD | 81.28% |
| 2019 FY | 5.67 Million USD | -72.52% |
| 2019 Q3 | 1.92 Million USD | -41.85% |
| 2019 Q1 | 1.82 Million USD | -61.26% |
| 2019 Q4 | -1.39 Million USD | -172.43% |
| 2018 Q2 | 5.53 Million USD | 20.83% |
| 2018 Q3 | 5.8 Million USD | 4.88% |
| 2018 FY | 20.63 Million USD | 33.95% |
| 2018 Q1 | 4.57 Million USD | 0.0% |
| 2018 Q4 | 4.71 Million USD | -18.73% |
| 2017 FY | 15.4 Million USD | 18.64% |
| 2016 FY | 12.98 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 95.032% |
| Addus HomeCare Corporation | 90.95 Million USD | 72.328% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | -165.412% |
| Amedisys, Inc. | 156.39 Million USD | 83.907% |
| American Oncology Network, Inc. | -49.15 Million USD | 151.204% |
| Astrana Health, Inc. | 84.61 Million USD | 70.254% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | -211.806% |
| IMAC Holdings, Inc. | -6.37 Million USD | 494.776% |
| biote Corp. | 28.65 Million USD | 12.172% |
| Cryo-Cell International, Inc. | -12.3 Million USD | 304.559% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | 77.67% |
| COMPASS Pathways plc | -136.91 Million USD | 118.382% |
| DocGo Inc. | 15.05 Million USD | -67.181% |
| The Ensign Group, Inc. | 255.36 Million USD | 90.144% |
| Healthcare Services Group, Inc. | 62.35 Million USD | 59.638% |
| InnovAge Holding Corp. | -23.18 Million USD | 208.581% |
| Assure Holdings Corp. | -20.08 Million USD | 225.331% |
| The Joint Corp. | -2.07 Million USD | 1314.083% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 113.307% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | 260.274% |
| ModivCare Inc. | -139.94 Million USD | 117.985% |
| NewGenIvf Group Limited | 42.24 Thousand USD | -59482.88% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | 394.265% |
| Option Care Health, Inc. | 314.59 Million USD | 92.0% |
| P3 Health Partners Inc. | -167.86 Million USD | 114.994% |
| P3 Health Partners Inc. | -167.86 Million USD | 114.994% |
| Surgery Partners, Inc. | 328 Million USD | 92.327% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | 971.624% |
| Talkspace, Inc. | -23.2 Million USD | 208.445% |
| Talkspace, Inc. | -23.2 Million USD | 208.445% |
| The Oncology Institute, Inc. | -77.01 Million USD | 132.679% |
| The Oncology Institute, Inc. | -77.01 Million USD | 132.679% |